Did not become law. It stopped in the Senate's Insurance and Real Estate Committee on January 26, 2017. The 2017 session has ended.
2017 Regular Session
Senate Bill 545
AN ACT CONCERNING A STUDY OF REQUESTS BY HEALTH CARE PROVIDERS TO OVERRIDE STEP THERAPY DRUG REGIMENS FOR CERTAIN CANCER PATIENTS.
What it does
The synopsis the General Assembly published with the bill.
To require a study and report on the processes that insurance companies, hospital service corporations, medical service corporations, health care centers and other entities that use step therapy for prescription drugs employ in assessing requests made by treating health care providers to override the use of step therapy drug regimens for insureds diagnosed with metastatic cancer and the response time to such requests.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
January 23 to January 26, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the SenateJan 23 to Jan 26 · stopped3 days
Insurance and Real Estate CommitteeJan 23 to Jan 26 · stopped3 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Jan 23
- Jan 23Introduced and sent to Insurance and Real Estate Committee
All 2 actions, as published
- Jan 23REF. TO JOINT COMM. ONBoth houses
- Jan 26Reserved for Subject Matter Public HearingBoth houses